All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Security
Security
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

Analysis: US-UK trade deal could force NHS to divert billions to medicines, critics warn

By

Lucy Hough, Aditya Chakrabortty, Leonore Schick, Sam Gruet, Ryan Ramgobin

1d ago· 1 min readenInsight

Summary

Analysis claims the US-UK trade deal agreed in December will force the NHS to divert billions from essential services to pay for new medicines, potentially causing over 200,000 excess deaths. The Labour government defends the deal as beneficial for British drug exports and patient access, while critics accuse them of bowing to pressure from Donald Trump. The piece is a short interview/opinion segment between Lucy Hough and columnist Aditya Chakrabortty.

Source

bskyAnalysis: US-UK trade deal could force NHS to divert billions to medicines, critics warntheguardian.com

Key quotes

· 2 pulled
The NHS will divert billions of pounds from essential services to pay for new medicines, under the terms of the US-UK trade deal agreed in December, which could lead to more than 200,000 excess deaths, analysis has found.
Ministers have defended the deal as a way of helping British drug exports avoid US tariffs and giving patients access to vital medication, but critics accuse the Labour party of caving into pressure from Donald Trump.
Snippet from the RSS feed
The NHS will divert billions of pounds from essential services to pay for new medicines under the terms of the US-UK trade deal agreed last December, which could lead to more than 200,000 excess deaths, analysis has found.Lucy Hough speaks to columnist Ad

You might also wanna read

Analysis: UK-US pharmaceuticals trade deal could divert NHS funds and harm public health

This article argues that the UK-US pharmaceuticals trade deal, announced on 1 December 2025, will harm public health by diverting billions o

bmj.com·2d ago

Analysis: UK-US pharmaceuticals trade deal could divert NHS funds and harm public health

This article argues that the UK-US pharmaceuticals trade deal, announced on 1 December 2025, will harm public health by diverting billions o

bmj.com·2d ago

Activists oppose NHS England's use of Palantir software for health records

The article is a strongly opinionated piece opposing NHS England's decision to roll out Palantir's software for managing health records. It

notopalantir.goodlawproject.org·19d ago

Activists oppose NHS England's use of Palantir software for health records

The article is a strongly opinionated piece opposing NHS England's decision to roll out Palantir's software for managing health records. It

notopalantir.goodlawproject.org·19d ago

U.S. restrictions on Chinese biotech could harm patients, argues editorial

The article argues against U.S. efforts to restrict collaboration with China's biotechnology industry, framing it as an extension of the tec

economist.com·14d ago

U.S. restrictions on Chinese biotech could harm patients, argues editorial

The article argues against U.S. efforts to restrict collaboration with China's biotechnology industry, framing it as an extension of the tec

The Economist·14d ago

EU Parliament Delays US Trade Deal Ratification After Trump's Greenland Tariff Threats

The European Parliament has frozen ratification of a key trade deal with the United States in response to President Donald Trump's tariff th

lemonde.fr·5mo ago

BFI Lobbied UK Government to Exclude Film and TV Industries from Trump Trade Deal

The British Film Institute (BFI) lobbied the UK government in May 2025 to exclude the country's film and TV industries from any trade deal w

Deadline·1mo ago

NYC Public Hospitals End Palantir Contract Amid UK Controversy Over Government Deals

New York City's public hospital system is ending its contract with Palantir, the controversial AI and data analytics firm, as the contract e

theguardian.com·3mo ago

Comments

Sign in to join the conversation.

No comments yet. Be the first.